COVID-19 vaccine protects kids and teens from severe illness: Study evaluated Pfizer-BioNTech vaccine effectiveness during the Delta and Omicron periods in children 5-18 years of age
Results of a new multicenter study published in the New England Journal of Medicine found that vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine reduced the risk…